John Forbes

Researcher Next ID · RN-008241

Researcher · Biochemistry, Genetics and Molecular Biology

Limerick, Ireland

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Breast Cancer Treatment Studies

Estrogen and related hormone effects

Advanced Breast Cancer Therapies

BRCA gene mutations in cancer

Cancer Treatment and Pharmacology

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30777-5
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt303
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)61963-1
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
The Lancet Oncology · 2010 · https://doi.org/10.1016/s1470-2045(10)70257-6
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(04)17666-6

No projects listed.